These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35397645)

  • 1. The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer.
    Yuk HD; Byun SS; Hong SK; Lee H
    Sci Rep; 2022 Apr; 12(1):6003. PubMed ID: 35397645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?
    Uhlman MA; Sun L; Stackhouse DA; Caire AA; Polascik TJ; Robertson CN; Madden J; Vollmer R; Albala DM; Moul JW
    Urology; 2010 Feb; 75(2):460-6. PubMed ID: 19819532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?
    Lee HJ; Han JH; Lee DH; Nam JK; Kim TN; Chung MK; Park SW
    Int J Urol; 2016 Sep; 23(9):758-63. PubMed ID: 27305865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy.
    Mandel P; Weinhold P; Michl U; Huland H; Graefen M; Tilki D
    Prostate; 2015 Sep; 75(13):1436-46. PubMed ID: 26074139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
    Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.
    Hinkelammert R; Eminaga O; Bettendorf O; Eltze E; Abbas M; Hertle L; Semjonow A
    Urol Oncol; 2014 May; 32(4):403-12. PubMed ID: 24332639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
    Pierorazio PM; Ross AE; Schaeffer EM; Epstein JI; Han M; Walsh PC; Partin AW
    J Urol; 2011 May; 185(5):1691-7. PubMed ID: 21419448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.
    Meyer CP; Hansen J; Boehm K; Tilki D; Abdollah F; Trinh QD; Fisch M; Sauter G; Graefen M; Huland H; Chun FK; Ahyai SA
    World J Urol; 2017 Feb; 35(2):199-206. PubMed ID: 27260503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostate-specific antigen value adjusted for non-cancerous prostate tissue volume in patients undergoing radical prostatectomy: a new predictor of biochemical recurrence in localized or locally advanced prostate cancer.
    Ku JH; Moon KC; Cho SY; Kwak C; Kim HH
    Asian J Androl; 2011 Mar; 13(2):248-53. PubMed ID: 21102474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study.
    Byun SS; Lee M; Hong SK; Lee H
    PLoS One; 2019; 14(11):e0224671. PubMed ID: 31697718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe approach to reduce over-treatment.
    Ting F; van Leeuwen PJ; Delprado W; Haynes AM; Brenner P; Stricker PD
    Prostate; 2015 Nov; 75(15):1768-73. PubMed ID: 26282713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The meaning of PSA progression after radical prostatectomy. Preliminary results].
    Luján Galán M; Pascual Mateo C; Rodríguez García N; Chiva Robles V; Escalera Almendros C; Angulo Cuesta J; Berenguer Sánchez A
    Actas Urol Esp; 2006 Apr; 30(4):353-8. PubMed ID: 16838606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of tumor volume with mortality following radical prostatectomy.
    Knoedler JJ; Karnes RJ; Thompson RH; Rangel LJ; Bergstralh EJ; Boorjian SA
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):144-8. PubMed ID: 24469091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
    Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
    Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
    Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
    Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.